Table 4.
Univariate Cox Proportional Hazard of 1‐Year Mortality
| Clinical Variables | HR | 95% CI | P Value |
|---|---|---|---|
| Thrombocytopenia | 2.34 | 1.46–3.44 | <0.001 |
| Age | 1.10 | 1.06–1.14 | <0.001 |
| Female sex | 0.71 | 0.46–1.10 | 0.123 |
| Previous diabetes mellitus | 2.13 | 1.10–4.12 | 0.025 |
| Previous AF | 0.78 | 0.51–1.20 | 0.257 |
| NYHA class III–IV | 1.96 | 1.27–3.04 | 0.003 |
| ALT | 1.01 | 1.00–1.01 | 0.112 |
| Total bilirubin | 1.02 | 1.01–1.03 | <0.001 |
| Anemia | 2.09 | 1.33–3.29 | 0.001 |
| eGFR <60 mL/min per 1.73 m2 | 1.99 | 1.14–3.48 | 0.016 |
| LA thrombus | 1.16 | 0.67–2.03 | 0.599 |
| Multivalvular heart disease | 1.18 | 0.62–2.22 | 0.618 |
| RV diameter | 1.04 | 1.02–1.07 | 0.001 |
| AVR | 1.57 | 1.02–2.41 | 0.039 |
| MVR | 0.43 | 0.22–0.86 | 0.017 |
| TVI | 1.38 | 0.78–2.45 | 0.272 |
| AVR+MVR | 1.30 | 0.85–2.00 | 0.233 |
| AVR+MVR+TVI | 1.46 | 0.94–2.26 | 0.094 |
| CABG surgery | 2.89 | 1.49–5.59 | 0.002 |
AF indicates atrial fibrillation; ALT, alanine transaminase; AVR, aortic valve replacement; CABG, coronary artery bypass grafting; CI, confidence interval; eGFR, estimated glomerular filtration rate; HR, hazard ratio; LA, left atrial; MVR, mitral valve replacement; NYHA, New York Heart Association; RV, right ventricular; and TVI, tricuspid valve intervention.